4
Changes in Ownership
BioAge Labs, Inc. Filed Acc 0001415889-24-024046
Director bought 400,000 shares at $18.00 ($7,200,000)
- Director acquired 1,310,589 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ENRIGHT PATRICK G Director | 2024-09-27 | Conversion | +1,310,589 | 1,310,589 | I | ||
| ENRIGHT PATRICK G Director | 2024-09-27 | Purchase | +400,000 | $18.00 | $7,200,000 | 1,710,589 | I |
| Derivatives | |||||||
| ENRIGHT PATRICK G Director | 2024-09-25 | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | D | ||
| ENRIGHT PATRICK G Director | 2024-09-27 | Conversion · Series D Preferred Stock | −5,848,637 | 0 | I | ||
| Open-market purchases · 400,000 sh · avg $18.00 · $7,200,000 | |||||||
Loading xslF345X05/form4-09272024_080937.xml…